Patients using insulin pump therapy had a better long-term glycemic control relative to the matched injection therapy cohort. Large population-based cohort studies using real-world data provide a valuable perspective on evaluation of new technologies in children with T1D.
No takes yet. Share an insight, caveat, or question.
Burckhardt et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: